INKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
MiNK Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$9.56+0.15 (+1.59%)
Close on Oct 19, 2026
- Market cap
- $48.02M
- P/E (TTM)
- –
- Dividend yield
- –
MiNK Therapeutics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | MiNK Therapeutics | Industry median |
|---|---|---|
| Market Cap | $48.78M | $166.30M |
| Enterprise Value | $39.98M | $88.19M |
Income (trailing twelve months)
| Measure | MiNK Therapeutics | Industry median |
|---|---|---|
| Operating Income | -$11.99M | -$21.40M |
| Net Income | -$11.36M | -$22.46M |
| EBITDA | -$11.99M | -$16.91M |
| EPS (Diluted) | -$2.40 | -$0.83 |
Returns
| Measure | MiNK Therapeutics | Industry median |
|---|---|---|
| Return on Assets (ROA) | -187.8% | -40.9% |
| Return on Capital Employed (ROCE) | -585.8% | -38.1% |
Balance sheet
| Measure | MiNK Therapeutics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $8.81M | $61.43M |
| Net Cash (Debt) | $8.81M | $15.35M |
| Net Cash Per Share | $1.73 | $0.66 |
| Equity (Book Value) | -$14.03M | $49.09M |
| Book Value Per Share | -$2.75 | $1.37 |
| Tangible Book Value | -$14.03M | $23.52M |
| Working Capital | $1.73M | $76.81M |
Financial position
| Measure | MiNK Therapeutics | Industry median |
|---|---|---|
| Current Ratio | 1.23 | 3.34 |
| Quick Ratio | 1.16 | 2.44 |
Cash flow (trailing twelve months)
| Measure | MiNK Therapeutics | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.83M | -$12.35M |
Efficiency
| Measure | MiNK Therapeutics | Industry median |
|---|---|---|
| Profits Per Employee | -$757.36K | -$703.34K |
| Employee Count | 15 | 74 |
Dividends and yields
| Measure | MiNK Therapeutics | Industry median |
|---|---|---|
| Earnings Yield | -23.3% | -23.3% |
Shares
| Measure | MiNK Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 5,103,000 | 58,127,000 |
| Shares Change (YoY) | 19.5% | 10.9% |
| Float | 4,866,460 | 49,136,700 |
| Shares Held by Insiders | 4.64% | 11.6% |
| Shares Held by Institutions | 4.01% | 59.4% |
Scores
| Measure | MiNK Therapeutics | Industry median |
|---|---|---|
| Altman Z-Score | -26.33 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from MiNK Therapeutics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.